Subsequent Events (Details) - USD ($) |
3 Months Ended | ||||
|---|---|---|---|---|---|
May 07, 2026 |
Mar. 31, 2026 |
Nov. 11, 2026 |
Aug. 07, 2026 |
Dec. 31, 2025 |
|
| Subsequent Events [Line Items] | |||||
| Deferred offering costs | $ 460,915 | ||||
| Working capital | $ 75,000 | ||||
| Legal fees | 75,000 | ||||
| Subsequent Events [Member] | |||||
| Subsequent Events [Line Items] | |||||
| Working capital | $ 75,000 | ||||
| Forecast [Member] | |||||
| Subsequent Events [Line Items] | |||||
| Percentage of interest rate of bearing | 0.00% | 16.00% | |||
| Notes [Member] | Related Party [Member] | |||||
| Subsequent Events [Line Items] | |||||
| Principal amount | $ 75,000 |
| X | ||||||||||
- Definition The amount of cash for working capital. No definition available.
|
| X | ||||||||||
- Definition Amount of principal of debt issued. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate. No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|